|
|
Volumn 18, Issue 2, 1998, Pages 89-95
|
|
Cancer in end-stage renal disease: Potential factors involved
a
|
|
Author keywords
Antioxidant capacity; Cancer incidence; Diuretics; DNA repair; End stage renal disease; Immunosuppressive medication
|
|
Indexed keywords
ANALGESIC AGENT;
ANTIOXIDANT;
CALCITRIOL;
CALCIUM CHANNEL BLOCKING AGENT;
DIMETHYLNITROSAMINE;
DIURETIC AGENT;
HETEROCYCLIC AMINE;
IMMUNOSUPPRESSIVE AGENT;
PARATHYROID HORMONE;
REACTIVE OXYGEN METABOLITE;
S ADENOSYLHOMOCYSTEINE;
ANTIOXIDANT ACTIVITY;
CANCER INCIDENCE;
CANCER RISK;
CANCER SUSCEPTIBILITY;
CARCINOGENESIS;
CARCINOGENIC ACTIVITY;
DNA REPAIR;
DRUG CARCINOGENICITY;
HEMODIALYSIS PATIENT;
HORMONAL CARCINOGENESIS;
HUMAN;
IMMUNE SYSTEM;
INFECTION;
INFLAMMATION;
KIDNEY CARCINOMA;
KIDNEY FAILURE;
KIDNEY METABOLISM;
LIVER CARCINOMA;
LONG TERM CARE;
LYMPHOMA;
MALIGNANT TRANSFORMATION;
METHYLATION;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
REVIEW;
TOBACCO;
UREMIA;
UTERUS CARCINOMA;
VITAMIN DEFICIENCY;
HUMANS;
KIDNEY FAILURE, CHRONIC;
NEOPLASMS;
RISK FACTORS;
|
|
EID: 0031902453
PISSN: 02508095
EISSN: None
Source Type: Journal
DOI: 10.1159/000013314 Document Type: Review |
|
Times cited : (165)
|
|
References (94)
|
